|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-11-27
|
|
pubmed:abstractText |
Genetic polymorphism of CYP2C19 is known to occur with a frequency of 12 per cent in north Indian population. But no study correlated CYP2C19 genetic polymorphism with eradication of Helicobacter pylori in north Indian gastritis patients positive for H. pylori and hence this study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0971-5916
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
130
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
437-43
|
|
pubmed:meshHeading |
pubmed-meshheading:19942749-Alkylating Agents,
pubmed-meshheading:19942749-Amoxicillin,
pubmed-meshheading:19942749-Anti-Bacterial Agents,
pubmed-meshheading:19942749-Anti-Ulcer Agents,
pubmed-meshheading:19942749-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:19942749-Genotype,
pubmed-meshheading:19942749-Helicobacter Infections,
pubmed-meshheading:19942749-Helicobacter pylori,
pubmed-meshheading:19942749-Humans,
pubmed-meshheading:19942749-India,
pubmed-meshheading:19942749-Omeprazole,
pubmed-meshheading:19942749-Phenotype,
pubmed-meshheading:19942749-Polymorphism, Genetic,
pubmed-meshheading:19942749-Tinidazole,
pubmed-meshheading:19942749-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Importance of CYP2C19 genetic polymorphism in the eradication of Helicobacter pylori in north Indians.
|
|
pubmed:affiliation |
Department of Biochemistry, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
